DOJ

Pharmalot Ed Silverman

Feds probe drug maker for prices of generic dermatology meds

Pharmalot Ed Silverman

Consumer safety agency says Indian company sold improperly packaged drugs

Pharmalot Ed Silverman

Two former device maker execs go on trial for unauthorized marketing

Pharmalot Ed Silverman

Novartis and the feds squabble over 80,000 ‘sham’ speaking events

Pharmalot Ed Silverman

FDA settles lawsuit, rescinds warning letter